Safety of treatment

European Respiratory Journal, Supplement

Volumn 9, Issue 21, 1996, Pages

  Bisgaard, H ^a   Pedersen, S ^b  

^a Rigshospitalet   (Denmark)

^b S/P Konsult ^*  (Denmark)

Author keywords

Adverse effects; Steroid; Young children

Indexed keywords

ANTIASTHMATIC AGENT; STEROID; THEOPHYLLINE;

ASTHMA; CATARACT; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOXICITY; HUMAN; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; WHEEZING; AGE; DOSE RESPONSE; PRESCHOOL CHILD; REVIEW; RISK FACTOR;

AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; RISK FACTORS; STEROIDS; TREATMENT OUTCOME;

EID: 0030119031     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (57)

1. Greenough A, Pool J, Gleeson JG, Price JF. Effect of budesonide on pulmonary hyperinflation in young asthmatic children. Thorax 1988, 43: 937-938.
2. Gleeson JG, Price JF. Controlled trial of budesonide given by the nebuhaler in preschool children with asthma. BMJ 1988; 297: 163-166.
3. Bisgaard H, Schiötz PO. Treatment of asthmatic bronchitis in young children with steroid inhalation. Ugeskr Laeger 1993; 155: 181-182.
4. Bisgaard H, Munck SL, Nielsen JP, Petersen W, Ohlsson SV. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990; 336: 649-651.
5. Connett GJ, Warde C, Wooler E, Lenney W. Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child 1993; 69: 351-355.
6. Ghigo E, Valetto MR, Gaggero L, Visca A, Valente Fe. Therapeutic doses of salbutamol inhibit the somatotropic responsiveness to growth hormone-releasing hormone in asthmatic children. J Endocrin Invest 1993; 16: 271-275.
7. Soferman R, Sapir N, Spirer Z, Golander A. Urinary growth hormone (U-GH) in asthmatic children. Eur Respir J 1995; 8 (Suppl. 19): 470.
8. Lipworth BJ. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995; 50: 105-110.
9. Bisgaard H, Anhoj J, Klug B, Berg E. Nonelectrostatic spacer for aerosol delivery. Arch Dis Child 1995; 73: 226-230.
10. Bisgaard H. Aerosol treatment of young children. Eur Respir Rev 1994; 4 (17): 15-20.
11. Karlberg J, Engstrom I, Karlberg P, Fryer JG. Analysis of linear growth using a mathematical model. 1. From birth to three years. Acta Paediatr Scand 1987; 76: 478-488.
12. Karlberg J, Gelander L, Albertsson-Wikland K. Distinctions between short- and long-term human growth studies. Acta Paediatr 1993; 82: 631-634.
13. Karlberg J, Low L, Yeung CY. On the dynamics of the growth process. Acta Paediatr 1994; 83: 777-778.
14. Thomas BC, Stanhope R, Grant DB. Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroids. Acta Paediatr 1994; 83: 196-199.
15. Marshall W. Evaluation of growth rate in height over periods of less than one year. Arch Dis Child 1971; 46: 414-420.
16. Butler GE, McKie M, Ratcliffe SG. The cyclical nature of prepubertal growth. Ann Hum Biol 1990; 17: 177-198.
17. Voss LD, Wilkin TJ, Bailey BJR, Betts PR. The reliability of height and height velocity in the assessment of growth (the Wessex Growth Study). Arch Dis Child 1991; 66: 833-837.
18. Wolthers OD, Pedersen S. Short-term linear growth in asthmatic children during treatment with prednisolone. BMJ 1990; 301: 145-148.
19. Varsano J, Volovitz B, Malik H, Amir Y. Safety of 1 year of treatment with budesonide in young children with asthma. J Allergy Clin Immunol 1990; 85: 914-920.
20. Ruiz RG, Price JF. Growth and adrenal responsiveness with budesonide in young asthmatics. Respir Med 1994; 88: 17-20.
21. Delacourt C, Chomienne F, DeBile J. Preservation of growth velocity in asthmatic children treated with high doses of beclomethasone dipropionate. Eur Respir J 1991; 4 (Suppl. 14): 593s.
22. Volovitz B, Amir J, Malik H, Kauschansky A, Varsano I. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 1993; 329: 1703-1733.
23. Bisgaard H. A metal aerosol holding chamber devised for young children with asthma. Eur Respir J 1995; 8: 856-860.
24. Wolthers OD, Pedersen S. Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ 1991; 303: 163-165.
25. Wolthers OD, Pedersen S. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics 1992; 89: 839-842.
26. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989; 30: 83-103.
27. Smith R. Corticosteroids and osteoporosis. Thorax 1990; 45: 573-575.
28. Greenberger PA, Hendrix RW, Patterson R, Chmiel JS. Bone studies in patients on prolonged systemic corticosteroid therapy for asthma. Clin Allergy 1982; 12: 363-368.
29. Adinoff AD, Hollister JR. Steroid-induced fracture and bone loss in patients with asthma. N Engl J Med 1983; 309: 265-268.
30. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatoid diseases. Arth Rheum 1985; 28: 361-368.
31. Meltzer EO, Kemp JP, Welch MJ, Orgel HA. Effect of dosing schdule on efficacy of beclomethasone dipropionate aerosol in chronic asthma. Am Rev Respir Dis 1985; 131: 732-736.
32. Byron MA, Jackson J, Ansell BM. Effect of different corticosteroid regimens on hypothalamic-pituitary-adrenal axis and growth in juvenile chronic arthritis. J R Soc Med 1983; 76: 452-457.
33. Sherman B, Weinberger M, Chen-Walden H, et al. Further studies of the effects of inhaled glucocorticoids on pituitary-adrenal function in healthy adults. J Allergy Clin Immunol 1982; 69: 208-212.
34. Law CM, Honour JW, Merchant JLe. Nocturnal adrenal supression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet 1986; i: 942-944.
35. Law CM, Preece MA, Warner JO. Nocturnal adrenal supression in children inhaling beclomethasone dipropionate. Lancet 1986; i: 321-323.
36. Tabacknik E, Zadik Z. Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. J Pediatrics 1991; 118: 294-297.
37. Philip M, Aviram M, Leiberman Ee. Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulmonol 1992; 12: 84-89.
38. Mosfeldt Laursen E, Kaae Hansen K, et al. Pulmonary function in adolescents with childhood asthma. Allergy 1993; 48: 267-272.
39. Yaacob I, Mohammad M. Pulmonary function in symptom-free asthmatics. Singapore Med J 1993; 34 (6): 522-523.
40. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332: 133-138.
41. Kelly WJ, Hudson I, Raven J, Phelan PD, Pain MC, Olinsky A. Childhood asthma and adult lung function. Am Rev Respir Dis 1988; 138: 26-30.
42. Kokkonen J, Linna O. The state of childhood asthma in young adulthood. Eur Respir J 1993; 6: 657-661.
43. Agertoft L, Pedersen S. Effects of long term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-381.
44. Haahtela T, Järvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700-705.
45. Selroos O, Backman R, Forsen KO, et al. The effect of inhaled corticosteroids in asthma is related to the duration of pretreatment symptoms. Am J Respir Crit Care Med 1994; 149: A211.
46. Spaeth GP, Von Smallman L. Corticosteroids and cataracts. Int Ophthalmol Clin 1966; 6: 915-929.
47. Bhagat RG, Chai H. Development of posterior subcapsular cataracts in asthmatic children. Pediatrics 1984; 73: 626-630.
48. Massarano AA, Hollis S, Devlin J, David TJ. Growth in atopic eczema. Arch Dis Child 1993; 68: 677-679.
49. Agertoft L, Pedersen S. Bone density in children during long-term treatment with budesonide. Eur Respir J 1993; 6: 261S.
50. Nassif E, Weinberger M, Sherman B, Brown K. Extrapulmonary effects of maintenance corticosteroids therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol 1987; 80: 518-529.
51. Simons FER, Persaud MP, Gillespie CA, Cheang M, Shuckett EP. Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet 1993; 342: 776-778.
52. Sevel D, Weinberg EG, van Niekerk CH. Lenticular complications of long-term steroid therapy in children with asthma and eczema. J Allergy 1977; 60: 215-217.
53. Toogood JH, Markov AE, Baskerville J, Dyson C. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. J Allergy Clin Immunol 1993; 91: 571-579.
54. Cogswell JJ, Simpkiss MJ. Nebulised sodium cromoglycate in recurrently wheezy preschool children. Arch Dis Child 1985; 60: 736-738.
55. Resnick A, Greenberger PA. A corticosteroid program for prevention of hospitalization for status asthmaticus in children. NER Allergy Proc 1987; 8: 104-107.
56. Litovitz TL, Holm KC, Bailey KM, Schmitz BF. 1991 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1992; 10: 452-505.
57. Shannon M, Lovejoy F. Effect of acute versus chronic intoxication on clinical features of theophylline poisoning in children. J Pediatr 1992; 121: 125-130.